VHPB Centre for Evaluation of Vaccination (CEV) |
Executive Secretary Administrative and Scientific Secretariat |
privacy statement
|
Meeting objectives:
Background document (Pdf, 6.730 kB)
Wednesday 30 October 2019
Session 1: Opening and objectives
Chairs: Zsuzsa Schaff – Johannes Hallauer
09:00 - 09:30
Session 2: The health care system in Hungary
09:30 – 10:00 Introduction in the health care system of Hungary (Pdf, 1.670 kB), Dr.Péter Csányi (deputy secretary of Health - EMMI)
10:00 - 10:20 Questions
Session 3: Current viral hepatitis situation, Epidemiology, screening, burden of disease in Hungary
10:20 - 10:50 Hepatitis: surveillance and epidemiological situation, Epidemiology of hepatitis in Hungary (Pdf, 1.051 kB), Dr.Cecilia Müller (head, NNK)
10:50 - 11:15 Coffee break
Chairs: Gabriella Pár – Rui Tato Marinho
11:15 - 11:40 Disease Burden in Hungary: chronic viral hepatitis and liver disease in Hungary (Pdf, 319 kB), Prof. Istvan Tornai
11:40 - 12:00 Overview of Hepatitis surveillance and Epidemiology in Europe (Pdf, 984 kB), Erika Duffel, ECDC
12:00 - 12:10 Question and discussion
12:10 - 12:30 Treatment and follow up of HCV-related liver disease (Pdf, 177 kB) (Dr Mihály Makara) & Chronic HCV diagnostic methods in Hungary 1992-2019 (Pdf, 986 kB) (Dr Judit Gervain)
Dr.Mihály Makara, Dr.Gervain Judit
12:30 - 12:40 Questions
12:40 - 13:30 Lunch
Chairs: Ferenc Szalay – Vladimir Chulanov
13:30 – 13:50 Hepatitis in Risk groups in Hungary, Screening programmes among injecting drug users in Hungary. Maria Dudas - Horváth-Tarján Anna
14:00 – 14:15 Screening in emergency units (Pdf, 142 kB), Prof. Istvan Tornai
14:15 – 14:30 Screening by family doctors (Pdf, 932 kB), Prof. Ferenc Szalay
14:30 – 14:45 HCV screening in homosexual communities (Pdf, 210 kB), Dr. Eszter Újhelyi
14:45 - 15:00 Questions
15:00 - 15:20 Optimization of screening strategies for viral hepatitis (Pdf, 2.334 kB), John Ward (Coalition for Global Hepatitis Elimination The Task Force for Global Health )
15:20- 15:30 Question and discussion
15:30- 15:50 Coffee break
Session 4: Prevention of viral hepatitis
Chairs: Istaván Vályi-Nagy - Vana Papaevangelou
15:50- 16:10 Vaccination programs in Hungary (Pdf, 429 kB), Dr. Zsuzsanna Molnár
16:10- 16:30 Hepatitis vaccination worldwide: Lessons learnt and the way forward (Pdf, 3.742 kB), Pierre Van Damme (Vaccine and Infectious Disease Institute, University, Antwerp, Belgium)
16:30- 16:40 Question and discussion
Session 5: Control of viral hepatitis
16:40- 17:00 Hepatitis case finding – Screening programmes and cascade of care in Hungary - Hepatitis research in Hungary, from identification to treatment (Pdf, 10.065 kB), Prof. Zsuzsa Schaff
17:00- 17:20 EASL Hepatitis treatment strategies in the framework of elimination of viral hepatitis as a public health threat (Pdf, 2.220 kB), Mojca Maticic (Head Department Viral Hepatitis, University medical Centre Ljubljana, Slovenia)
17:20- 17:40 Question and discussion
19:45 Dinner
Thursday 31 October 2019
Session 6: National hepatitis plan and the different stakeholders
Chairs: Béla Hunyady – David Goldberg
08:30- 08:50 The Hungarian Hepatitis Committee. National program for chronic viral hepatitis elimination (Pdf, 246 kB), Prof. Béla Hunyady
08:50- 09:10 Financial aspects of HCV elimination. Is it „cost saving”? Cost of screening and treatment (Pdf, 342 kB), Dr. Aron Zoltán Vincziczki (NEAK)
09:10- 09:30 Best practices: National Hepatitis approach of Slovenia (Pdf, 3.210 kB), Mojca Maticic (Head Department Viral Hepatitis, University medical Centre Ljubljana, Slovenia)
09:30- 09:40 Question and discussion
09:40- 10:00 Prevention and control activities by Civil society and patient organisation (Pdf, 1.658 kB) VIMOR Hepatitis patient organisation / Hungarian Liver Patients Association, Antalné Nagy
10:00- 10:20 Question and discussion
10:20- 11:00 Coffee break
Session 7: groups discussion - What are the needs to Eliminate viral hepatitis by 2030
Chairs: Mihály Makar – Daniel Lavanchy
11:00- 11:20 WHO Global Strategy and the European action plan for viral hepatitis elimination, including WHO/Europe good practices (Pfd, 1.966 kB), Antons Mozalevskis, (WHO Regional Office for Europe)
11:20 - 12:30 Groups or Panel discussion: Assess the needs to achieve the WHO’s Regional office for Europe- targets for elimination viral hepatitis in Hungary by 2030
Group 1 - Epidemiological surveillance, screening, monitoring and analysis of the effectiveness of prevention and treatment programs, informing the public
Group 2 - Prevention of viral hepatitis: improvement of vaccine prevention programs, prevention in high-risk groups, prevention in health care settings
Group 3 - Treatment of viral hepatitis: recommendations based on epidemiology and disease burden data, increasing access to treatment, coverage of the most affected groups
12:30-13:00 Presentation outcome of the groups sessions
13:00-14:30 Lunch
Session 8: Conclusion of the meeting
Chairs: Zsuzsa Schaff – Daniel Shouval
14:30 – 15:30 Conclusion of the meeting + Final discussion (draft will be updated; Pdf, 170 kB), David FitzSimons